Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study

Yashashwi Pokharel1, Wensheng Sun2, Salim S Virani3

  • 1Section of Cardiology, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas; Saint Luke's Mid-America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri.

JACC. Heart Failure
|December 27, 2016
PubMed

Insights

Subclinical myocardial injury predicts higher heart failure (HF) mortality, but does not explain the obesity paradox. Overweight and obese individuals with HF still show lower mortality, regardless of injury levels.

Area of Science:

  • Cardiology
  • Clinical Research
  • Biomarkers

Background:

  • Obesity is a known risk factor for heart failure (HF).
  • Pre-HF obesity is paradoxically associated with lower mortality post-diagnosis.
  • High-sensitivity cardiac troponin T (hs-cTnT) indicates myocardial injury and predicts HF outcomes.

Purpose of the Study:

  • To investigate if pre-HF myocardial injury explains the differential mortality observed across weight categories after HF.
  • To examine the association between pre-HF hs-cTnT levels, body mass index (BMI), and mortality in individuals hospitalized with HF.

Main Methods:

  • Analysis of 1,279 individuals with incident HF hospitalizations from the ARIC study.
  • Stratification based on pre-HF hs-cTnT levels (< 14 ng/l vs. ≥ 14 ng/l).
  • Examination of the association between pre-HF BMI and mortality, adjusting for hs-cTnT and other factors.

Main Results:

  • Individuals with higher pre-HF hs-cTnT (≥ 14 ng/l) faced increased mortality post-HF hospitalization (HR: 1.46).
  • Overweight and obese individuals exhibited lower mortality compared to normal weight individuals, irrespective of hs-cTnT levels.
  • The obesity paradox persisted even after adjusting for subclinical myocardial injury and other covariates.

Conclusions:

  • Elevated pre-existing subclinical myocardial injury is linked to higher mortality after HF hospitalization.
  • Subclinical myocardial injury does not account for the observed obesity paradox in heart failure.
  • The lower mortality risk in overweight and obese individuals with HF is independent of pre-HF myocardial injury levels.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
857
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
597
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K